16:47 CORT Corcept Therapeutics resumes trading about 43% higher at $4.32 on light volume following news that the FDA approved Korlym (see 16:20 posts) (3.03 +0.15)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.